Pasithea Therapeutics KTTA Q4 2025 Annual earnings
Reported March 30, 2026 · After market close
EPS-$0.89Miss by $0.71
Revenue estimate$100.0K
EPS estimate-$0.18
Next report
Date not yet announcedVersus estimates
Diluted EPS
Q1 2026-$0.12Beat by $0.33
Q4 2025-$0.89Miss by $0.71
Q4 2026-$0.18In lineQ3 2025-$0.41Q2 2025-$0.66Q1 2025-$1.61Ask the moment Pasithea Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Pasithea Therapeutics report Q4 2025 earnings?
- Pasithea Therapeutics (KTTA) reported Q4 2025 earnings on March 30, 2026 after market close.
- What were Pasithea Therapeutics's Q4 2025 revenue and EPS?
- Pasithea Therapeutics reported eps of $-0.89 for Q4 2025.
- Did Pasithea Therapeutics beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.18 by $0.71.
- How did Pasithea Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 63.1% from $-2.41.
- Where can I find Pasithea Therapeutics's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001213900-26-036434) directly on SEC EDGAR. The filing index links above go to sec.gov.